NCT01961102View on ClinicalTrials.gov

OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

March 31, 2016

Conditions
Endometrial CancerAtypical Hyperplasia
Interventions
PROCEDURE

hysteroscopy/curettage in case of suspicious aspect will be done a rapid section

Trial Locations (1)

4020

Department of Gynaecology, Barmherzige Schwestern, Linz

All Listed Sponsors
lead

Krankenhaus Barmherzige Schwestern Linz

OTHER

NCT01961102 - OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer | Biotech Hunter | Biotech Hunter